- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速下跌的趋势。
- 长期趋势：
已有61家主力机构披露2025-12-31报告期持股数据，持仓量总计3887.88万股，占流通A股28.23%
- 波段诊断：
-
技术面诊股
诊断结果：3.2技术面打败了22%的股票
技术面评分前10的股票
近期的平均成本为12.54元。空头行情中，并且有加速下跌的趋势。
平均成本
近期的平均成本为12.54元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"12.54","date":1781683552,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2026.06.18","stock":"0.40","trade":null,"ind":"0.94"},{"date":"2026.06.17","stock":"-3.10","trade":null,"ind":"1.31"},{"date":"2026.06.16","stock":"0.31","trade":null,"ind":"0.93"},{"date":"2026.06.15","stock":"-0.54","trade":null,"ind":"3.79"},{"date":"2026.06.12","stock":"2.37","trade":null,"ind":"0.75"},{"date":"2026.06.11","stock":"-1.40","trade":null,"ind":"-0.68"},{"date":"2026.06.10","stock":"-1.31","trade":null,"ind":"-2.06"},{"date":"2026.06.09","stock":"0.00","trade":null,"ind":"3.02"},{"date":"2026.06.08","stock":"-3.06","trade":null,"ind":"-3.22"},{"date":"2026.06.05","stock":"2.60","trade":null,"ind":"-2.21"},{"date":"2026.06.04","stock":"-2.90","trade":null,"ind":"-0.27"},{"date":"2026.06.03","stock":"-2.39","trade":null,"ind":"0.73"},{"date":"2026.06.02","stock":"-2.89","trade":null,"ind":"1.63"},{"date":"2026.06.01","stock":"1.79","trade":null,"ind":"-1.51"},{"date":"2026.05.29","stock":"-1.41","trade":null,"ind":"-1.81"},{"date":"2026.05.28","stock":"-0.56","trade":null,"ind":"0.80"},{"date":"2026.05.27","stock":"-2.13","trade":null,"ind":"-0.88"},{"date":"2026.05.26","stock":"-2.09","trade":null,"ind":"0.12"},{"date":"2026.05.25","stock":"-1.90","trade":null,"ind":"1.66"},{"date":"2026.05.22","stock":"0.93","trade":null,"ind":"2.30"},{"date":"2026.05.21","stock":"-2.89","trade":null,"ind":"-2.07"}]
透景生命,深证成指,医疗器械指数
压力支撑
该股压力位为12.47元，支撑位为12.20元。
[{"text":"\u538b\u529b\u4f4d","value":"12.47","date":1781712000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"12.20","date":1781712000,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.1资金面打败了64%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：06月18日 16:54
| 机构今日流向(万元) | -423.71 | 机构5日流向(万元) | -1825.95 |
| 机构10日流向(万元) | -4284.04 | 机构20日流向(万元) | -10246.76 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量增加491.27万股，其中基金净增仓1家，主力净减仓16家，请投资者中长期谨慎为宜。
截止2025-12-31，共61家主力机构（基金54家，阳光私募1家，一般法人4家，QFII2家），持仓量总计3887.88万股，占流通A股28.23%
其中，基金持仓与2025-06-30相比：
增仓：12家 ，增持 55.83万股
减仓：11家 ，减持 15.45万股
新出现在主力名单中：32家 ，持有876.64万股
从主力名单中消失：48家 ，原持有263.87万股
其中，基金持仓与2025-06-30相比：
增仓：12家 ，增持 55.83万股
减仓：11家 ，减持 15.45万股
新出现在主力名单中：32家 ，持有876.64万股
从主力名单中消失：48家 ，原持有263.87万股
消息面诊股
诊断结果：5.9消息面打败了33%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 从泡沫到出清 体外诊断行业“赚快钱”时代已然落幕
2026-06-09 - 聚焦肌炎精准诊断，透景生命肌炎自身抗体谱亮相第六届
2026-06-02 - 透景生命：人类免疫缺陷病毒抗原抗体联合检测试剂盒(
2026-05-25 - 透景生命携“星”品亮相第九届中国妇儿临床诊断与实验
2026-05-21 - 透景生命：控股子公司康录生物通过高新技术企业重新认
2026-05-19 - 透景生命2025年全年每10股派1元 股权登记日
2026-05-19 - 透景生命：子公司甲预生命取得一项检测高度侵袭性肿瘤
2026-05-18 - 透景生命：5月15日召开业绩说明会，投资者参与
2026-05-18 - 第二十三次子宫颈癌协作组会议，透景生命再获“社会公
2026-05-06 - 透景生命：持股5%以上股东凌飞集团解除质押1100
2026-05-06
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-05-06 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-25 |
| 利好 | 分红转增 | 10派1元(含税) | 2026-04-25 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-04-25 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-25 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2026-01-29 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-27 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-27 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-27 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了3%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.06.18","price":"0.94","value":null},{"date":"2026.06.17","price":"1.31","value":null},{"date":"2026.06.16","price":"0.93","value":null},{"date":"2026.06.15","price":"3.79","value":null},{"date":"2026.06.12","price":"0.75","value":null},{"date":"2026.06.11","price":"-0.68","value":null},{"date":"2026.06.10","price":"-2.06","value":null},{"date":"2026.06.09","price":"3.02","value":null},{"date":"2026.06.08","price":"-3.22","value":null},{"date":"2026.06.05","price":"-2.21","value":null},{"date":"2026.06.04","price":"-0.27","value":null},{"date":"2026.06.03","price":"0.73","value":null},{"date":"2026.06.02","price":"1.63","value":null},{"date":"2026.06.01","price":"-1.51","value":null},{"date":"2026.05.29","price":"-1.81","value":null},{"date":"2026.05.28","price":"0.80","value":null},{"date":"2026.05.27","price":"-0.88","value":null},{"date":"2026.05.26","price":"0.12","value":null},{"date":"2026.05.25","price":"1.66","value":null},{"date":"2026.05.22","price":"2.30","value":null},{"date":"2026.05.21","price":"-2.07","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 力诺药包 | 54.73% | 21.87% | 6.4分 |
| 2 | 爱迪特 | 45.08% | 39.82% | 6.2分 |
| 3 | 华兰股份 | 17.84% | 5.59% | 5.9分 |
| 4 | 正川股份 | 17.73% | 2.24% | 5.4分 |
| 5 | 万孚生物 | 9.32% | 2.11% | 4.6分 |
| 6 | 威高血净 | 7.38% | 12.65% | 5.5分 |
| 8 | 山东药玻 | 4.92% | 2.77% | 4.9分 |
| 10 | 九安医疗 | 3.59% | 19.06% | 5.4分 |
| 12 | 大博医疗 | 1.81% | 2.35% | 6.3分 |
| 14 | 五洲医疗 | 0.31% | -5.08% | 3.8分 |
| 16 | - | -0.50% | 24.99% | 分 |
| 18 | 振德医疗 | -0.84% | 6.24% | 5.4分 |
| 20 | 奕瑞科技 | -1.31% | 2.22% | 5.3分 |
| 22 | 天智航 | -1.62% | 11.33% | 4.6分 |
| 24 | 洁特生物 | -2.01% | 17.60% | 4.5分 |
| 26 | 东方海洋 | -3.80% | 0.57% | 4.1分 |
| 28 | 利德曼 | -4.08% | -11.33% | 4.5分 |
| 30 | 安图生物 | -4.18% | -1.84% | 4.3分 |
| 32 | 东星医疗 | -4.53% | -0.75% | 4.5分 |
| 34 | 南卫股份 | -4.94% | 2.12% | 4.6分 |
| 36 | 海泰新光 | -5.27% | 5.97% | 5.3分 |
| 38 | 乐心医疗 | -5.40% | 8.36% | 4.8分 |
| 40 | 康德莱 | -5.84% | -1.25% | 4.3分 |
| 42 | 东富龙 | -6.60% | 5.20% | 4.9分 |
| 44 | 采纳股份 | -7.17% | 6.72% | 4.6分 |
| 46 | 奥美医疗 | -8.05% | 8.99% | 5.7分 |
| 48 | ST凯利 | -8.55% | 1.81% | 5.0分 |
| 50 | - | -8.64% | 0.77% | 分 |
| 52 | 西山科技 | -8.87% | 6.89% | 5.3分 |
| 54 | 天臣医疗 | -9.15% | 2.06% | 4.5分 |
| 56 | 基蛋生物 | -9.40% | 3.45% | 4.1分 |
| 58 | 楚天科技 | -9.55% | 4.01% | 4.7分 |
| 60 | 微电生理 | -9.71% | -4.17% | 4.7分 |
| 62 | 宝莱特 | -9.91% | 19.96% | 5.1分 |
| 64 | 戴维医疗 | -9.98% | 1.47% | 3.9分 |
| 66 | 春立医疗 | -10.08% | 2.64% | 4.4分 |
| 68 | - | -10.54% | 2.51% | 分 |
| 70 | 美康生物 | -11.33% | -1.65% | 3.9分 |
| 72 | 昊海生科 | -11.64% | -0.43% | 3.8分 |
| 74 | 东方生物 | -11.74% | -0.21% | 3.6分 |
| 76 | 维力医疗 | -11.87% | 0.96% | 4.3分 |
| 78 | 普门科技 | -12.22% | -2.33% | 4.5分 |
| 80 | 国发股份 | -12.46% | 1.02% | 4.5分 |
| 82 | 冠昊生物 | -12.84% | 3.75% | 3.9分 |
| 84 | 中源协和 | -13.20% | 0.88% | 4.5分 |
| 86 | 三诺生物 | -13.34% | -1.38% | 4.9分 |
| 88 | 健帆生物 | -13.59% | -4.85% | 4.1分 |
| 90 | 惠泰医疗 | -13.65% | -4.02% | 4.8分 |
| 92 | 热景生物 | -14.00% | -1.80% | 4.2分 |
| 94 | 达安基因 | -14.35% | 4.91% | 4.6分 |
| 96 | 港通医疗 | -14.69% | -4.76% | 4.3分 |
| 98 | 硕世生物 | -14.80% | -1.40% | 4.2分 |
| 100 | 蓝帆医疗 | -15.02% | -2.10% | 4.8分 |
| 102 | 迈克生物 | -15.08% | -1.87% | 3.6分 |
| 104 | 浩欧博 | -15.27% | 8.88% | 4.0分 |
| 106 | 英科医疗 | -15.48% | -13.02% | 3.8分 |
| 108 | 安旭生物 | -15.80% | -4.47% | 3.8分 |
| 110 | 爱朋医疗 | -15.88% | 2.93% | 3.8分 |
| 112 | - | -16.06% | -2.72% | 分 |
| 114 | 济民健康 | -16.09% | -0.13% | 3.6分 |
| 116 | 奥精医疗 | -16.82% | -2.60% | 3.7分 |
| 118 | - | -17.09% | -2.53% | 分 |
| 120 | 黄山胶囊 | -17.18% | -4.34% | 4.7分 |
| 122 | 威高骨科 | -17.37% | 0.05% | 4.4分 |
| 124 | 健尔康 | -17.89% | -2.66% | 4.5分 |
| 126 | 安必平 | -18.50% | 0.10% | 3.9分 |
| 128 | 瑞迈特 | -18.59% | -4.40% | 4.8分 |
| 130 | 北芯生命 | -18.96% | 6.08% | 5.7分 |
| 132 | 康为世纪 | -19.05% | -1.98% | 3.8分 |
| 134 | 拱东医疗 | -19.38% | -2.79% | 4.6分 |
| 136 | 三友医疗 | -23.73% | -0.25% | 3.7分 |
| 138 | 中红医疗 | -24.96% | -4.39% | 4.6分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 108/243 ， 38/243。
[{"date":"2026-03-31","value":"-0.39","vol":"1.15"},{"date":"2025-12-31","value":"0.24","vol":"2.66"},{"date":"2025-09-30","value":"0.39","vol":"2.97"},{"date":"2025-06-30","value":"0.18","vol":"2.34"},{"date":"2025-03-31","value":"0.03","vol":"1.15"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-0.39 | 0.24 | 0.39 | 0.18 | 0.03 |
| 行业(%) | 1.15 | 2.66 | 2.97 | 2.34 | 1.15 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"64.87","vol":"52.18"},{"date":"2025-12-31","value":"69.56","vol":"51.61"},{"date":"2025-09-30","value":"66.60","vol":"51.74"},{"date":"2025-06-30","value":"65.66","vol":"52.05"},{"date":"2025-03-31","value":"63.66","vol":"51.74"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
64.87 | 69.56 | 66.60 | 65.66 | 63.66 |
| 行业(%) | 52.18 | 51.61 | 51.74 | 52.05 | 51.74 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 44/243 ， 129/243。
[{"date":"2026-03-31","value":"10.30","vol":"5.49"},{"date":"2025-12-31","value":"-16.70","vol":"1.44"},{"date":"2025-09-30","value":"-19.73","vol":"0.26"},{"date":"2025-06-30","value":"-26.25","vol":"-1.09"},{"date":"2025-03-31","value":"-19.53","vol":"-0.12"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
10.30 | -16.70 | -19.73 | -26.25 | -19.53 |
| 行业(%) | 5.49 | 1.44 | 0.26 | -1.09 | -0.12 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-1278.90","vol":"-16.14"},{"date":"2025-12-31","value":"-89.61","vol":"-25.45"},{"date":"2025-09-30","value":"-76.33","vol":"-15.37"},{"date":"2025-06-30","value":"-58.41","vol":"-18.14"},{"date":"2025-03-31","value":"110.51","vol":"-2.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-1278.90 | -89.61 | -76.33 | -58.41 | 110.51 |
| 行业(%) | -16.14 | -25.45 | -15.37 | -18.14 | -2.57 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 106/243 ， 96/243。
[{"date":"2026-03-31","value":"0.04","vol":"0.08"},{"date":"2025-12-31","value":"0.19","vol":"0.35"},{"date":"2025-09-30","value":"0.14","vol":"0.25"},{"date":"2025-06-30","value":"0.09","vol":"0.17"},{"date":"2025-03-31","value":"0.04","vol":"0.08"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.04 | 0.19 | 0.14 | 0.09 | 0.04 |
| 行业(次) | 0.08 | 0.35 | 0.25 | 0.17 | 0.08 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.29","vol":"0.55"},{"date":"2025-12-31","value":"1.05","vol":"2.33"},{"date":"2025-09-30","value":"0.79","vol":"1.66"},{"date":"2025-06-30","value":"0.52","vol":"1.12"},{"date":"2025-03-31","value":"0.25","vol":"0.54"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.29 | 1.05 | 0.79 | 0.52 | 0.25 |
| 行业(次) | 0.55 | 2.33 | 1.66 | 1.12 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"10.02","vol":"0.09"},{"date":"2025-12-31","value":"37.78","vol":"32.02"},{"date":"2025-09-30","value":"37.37","vol":"14.74"},{"date":"2025-06-30","value":"59.24","vol":"15.54"},{"date":"2025-03-31","value":"21.91","vol":"4.16"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 10.02 | 37.78 | 37.37 | 59.24 | 21.91 |
| 行业 | 0.09 | 32.02 | 14.74 | 15.54 | 4.16 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.05","vol":"1.59"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"1.20","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.05 | - | 1.20 | - |
| 行业 | 0.00 | 1.59 | 0.01 | 1.57 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 82/243 ， 86/243。
[{"date":"2026-03-31","value":"5.38","vol":"6.20"},{"date":"2025-12-31","value":"4.91","vol":"5.29"},{"date":"2025-09-30","value":"11.00","vol":"5.66"},{"date":"2025-06-30","value":"8.26","vol":"5.47"},{"date":"2025-03-31","value":"13.95","vol":"5.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
5.38 | 4.91 | 11.00 | 8.26 | 13.95 |
| 行业 | 6.20 | 5.29 | 5.66 | 5.47 | 5.80 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"4.49","vol":"5.06"},{"date":"2025-12-31","value":"3.90","vol":"4.14"},{"date":"2025-09-30","value":"9.18","vol":"4.51"},{"date":"2025-06-30","value":"6.90","vol":"4.35"},{"date":"2025-03-31","value":"11.08","vol":"4.69"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
4.49 | 3.90 | 9.18 | 6.90 | 11.08 |
| 行业 | 5.06 | 4.14 | 4.51 | 4.35 | 4.69 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 39/243 ， 40/243。
[{"date":"2026-03-31","value":"26.79","vol":"21.96"},{"date":"2025-12-31","value":"28.02","vol":"22.90"},{"date":"2025-09-30","value":"23.63","vol":"22.07"},{"date":"2025-06-30","value":"13.17","vol":"22.01"},{"date":"2025-03-31","value":"10.33","vol":"21.02"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
26.79 | 28.02 | 23.63 | 13.17 | 10.33 |
| 行业(%) | 21.96 | 22.90 | 22.07 | 22.01 | 21.02 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.38","vol":"0.39"},{"date":"2025-12-31","value":"0.40","vol":"0.40"},{"date":"2025-09-30","value":"0.32","vol":"0.71"},{"date":"2025-06-30","value":"0.15","vol":"0.58"},{"date":"2025-03-31","value":"0.12","vol":"0.56"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.38 | 0.40 | 0.32 | 0.15 | 0.12 |
| 行业(%) | 0.39 | 0.40 | 0.71 | 0.58 | 0.56 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"1.25","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.89","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.35","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.04","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.14","blueLineValue":"0.08","type":"YC"}]